Format

Send to

Choose Destination
J Ultrasound Med. 2019 Mar;38(3):605-612. doi: 10.1002/jum.14727. Epub 2018 Aug 31.

Ultrasound-Guided Prolotherapy for Acromial Enthesopathy and Acromioclavicular Joint Arthropathy: A Single-Arm Prospective Study.

Hsieh PC1,2, Chiou HJ1,2,3, Wang HK1,2, Lai YC1,2, Lin YH1,2.

Author information

1
Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
2
School of Medicine, National Yang-Ming University, Taipei, Taiwan.
3
School of Medicine, National Defense Medical Center, Taipei, Taiwan.

Abstract

OBJECTIVES:

Prolotherapy is an injection-based complementary treatment for various musculoskeletal diseases. The aim of this study was to evaluate the therapeutic efficacy of ultrasound-guided prolotherapy in the treatment of acromial enthesopathy and acromioclavicular joint arthropathy.

METHODS:

Thirty-one patients with chronic moderate-to-severe shoulder pain were recruited from September 2015 to September 2017. Ultrasound-guided prolotherapy was performed by injecting 10 mL of a 15% dextrose solution into the acromial enthesis of the deltoid or acromioclavicular joint capsule aseptically. Prolotherapy was given in 2 sessions separated by a 1-month interval. The pretreatment-to-posttreatment change in the pain visual analog scale (VAS) score was recorded as the primary outcome. The mean follow-up duration was 61.8 days. A paired t test was used to assess the difference in pretreatment and posttreatment VAS scores. A univariate logistic regression analysis was conducted to identify the demographic variables associated with substantial pain reduction after the intervention. Substantial pain reduction was defined as a posttreatment VAS score of 3 or less.

RESULTS:

Twenty of the 31 patients reported substantial pain reduction without adverse effects after the intervention. The mean VAS score reduction ± SD was 4.3 ± 2.6 (pretreatment, 6.8 ± 1.5; posttreatment, 2.5 ± 2.1; P < .01).

CONCLUSIONS:

Ultrasound-guided prolotherapy with a 15% dextrose solution is an effective and safe therapeutic option for moderate-to-severe acromial enthesopathy and acromioclavicular joint arthropathy.

KEYWORDS:

acromial enthesopathy; acromioclavicular joint arthropathy; musculoskeletal; prolotherapy; ultrasound-guided injection

PMID:
30171616
DOI:
10.1002/jum.14727
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center